Menopausal women's health is an issue of public health policy

Taiwan Journal of Public Health

Volumn 22, Issue 4, 2003, Pages 245-250

  Chang, Chueh ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Double blind experiment; HRT; Menopause

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; GENDER; GYNECOLOGY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH SERVICE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL ETHICS; MENOPAUSE; NEGLECT; PUBLIC HEALTH; PUBLIC OPINION; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; TAIWAN; UNITED STATES;

EID: 1642536650     PISSN: 10232141     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in health postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
2. NWHN: Taking Hormones and Women's Health: Choices, Risks and Benefits. 5th edition, Washington D.C.: National Women's Health Network, 2000.
3. The Coronary Drug Project Research Group. The coronary drug project: initial findings leading to modifications of its research protocol. JAMA 1970;214:1303-13.
4. Helley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998, 280:605-13.
5. Freedman L, Anderson G, Kipnis V, et al. Approaches to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative. Cont Clin Tri 1996;17:509-25.
6. Rosenberg L. Hormone replacement therapy: the need of reconsideration. Am J Public Health 1993;83:1670-2.
7. World Health Organization. WHO calls for strong focus on health promotion for women. Press Release, 2002/7/16. Available from: URL: http://www.who.int/inf/en/note2002-03.html
8. Chang C, Lin HW. Randomized, double-blind, placebo-controlled HRT trials and HRT studies in Taiwan- a review. KJMS 2003;19:257-69.
9. Humphries KH, Gill S. Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ 2003;168:1001-10.
10. Love S, Lindsay K. Dr Susan Love's Hormone Book. New York: Random House, 1997;16-37.
11. Guide to Clinical Preventive Services. Report of the US Preventive Services Task Force. 2nd ed. New York: Lippincott Williams & Wilkins, 1996: xxv-xxxviii.